MJNA President and CEO discussed cannabis investment opportunities illuminated by Attorney General Jeff Sessions’ rescission of state-legal marijuana protections.
Dr. Stuart Titus, President and CEO of Medical Marijuana, Inc., was featured in an article published recently by Entrepreneur.
The national business publication’s report, titled “Why Jeff Sessions’ New War on Marijuana Hasn’t Frightened Investors or Cannabis Entrepreneurs,” investigates the potential market impact of United States Attorney General Jeff Sessions’ recent rescission of the Cole Memo, a federal policy that protected state-legal marijuana. The move allows federal prosecutors and law enforcement to interfere with state-legal adult use marijuana operations.
While the new federal policy has created angst in some within the cannabis industry, according to the Entrepreneur article the market’s response to the announcement “inadvertently revealed just how entrenched the cannabis industry has already become.” The piece explained that Sessions’ announcement caused only a minor blip in cannabis investment activities before they quickly rebounded.
For the Entrepreneur article, contributor Andre Bourque interviewed various cannabis industry leaders, including Dr. Titus, executive of MJNA, the first publicly traded cannabis company in the United States.
In the article, Dr. Titus conveyed that periods of low stock prices offer a “prime time” opportunity for investors to get involved in the cannabis industry for the first time. He added that historically cannabis investors have benefitted from “[buying] stocks when they are relatively out of favor (i.e. this week).”
Further, Dr. Titus noted that the strong opposition to Sessions’ new policy indicates that the country is moving closer to nationwide legalization of medical cannabis. Criticism of Sessions by advocates, business owners, and lawmakers – Democrats and Republicans — was swift and widespread.
In conclusion, the Entrepreneur article suggests that despite the Attorney General’s new policy indicating an intention to resume federal enforcement of marijuana laws, there are various reasons for “holding tight or even growing investment in U.S. cannabis stocks and companies.”
Read the full article from Entrepreneur HERE.
Learn More about MJNA
While MJNA supports the legalization of cannabis, the rescinding of the Cole Memo and the laws related to it in no way affect MJNA or its subsidiaries, which sell only cannabidiol (CBD) products derived from hemp. You can read the Company’s official response to the new federal policy HERE.
You can learn more about Medical Marijuana, Inc. and its portfolio of companies by visiting our news feed.